Emerging Data and Treatment Trends in Paroxysmal Nocturnal Hemoglobinuria After EHA 2025 - Episode 3
Implications of the FDA Approval of Iptacopan for PNH
Austin Kulasekararaj, MBBS, MD, MRCP, FRCPath, and David Dingli, MD, PhD, on the implications of the FDA approval of Iptacopan for PNH.
Related Content:
